ABSTRACT Effects of hirsutine, an alkaloid that produces a potent ganglion block ing effect, were investigated using rat pheochromocytoma PC12 cells. Hirsutine (1 to 10 ,uM) suppressed dopamine-release evoked by 1.00 ,uM nicotine. In voltage-clamped cells, hirsutine (1 to 10 ,u M) inhibited the inward current activated by 100 ,U M nico tine. Hirsutine was equipotent to hexamethonium in blocking the nicotine-activated current. The voltage-dependency of the nicotine activated current was not modified by hirsutine. Effects of hirustine on other ion channels were tested to determire its selec tivity. Inward currents mediated through ATP-activated channels were scarcely affected by hirsutine (up to 100 1uM). However, hirustine (10,uM) inhibited Ba cur rents passing through Ca channels and K currents activated by depolarizing voltage steps. The results suggest that hirsutine potently blocks nicotinic receptor-channels, but hirsutine also inhibits voltage-gated Ca and K channels. Roles of the inhibition of these channels in the pharmacological effects of hirsutine were discussed.
ABSTRACT Effects of hirsutine, an alkaloid that produces a potent ganglion block ing effect, were investigated using rat pheochromocytoma PC12 cells. Hirsutine (1 to 10 ,uM) suppressed dopamine-release evoked by 1.00 ,uM nicotine. In voltage-clamped cells, hirsutine (1 to 10 ,u M) inhibited the inward current activated by 100 ,U M nico tine. Hirsutine was equipotent to hexamethonium in blocking the nicotine-activated current. The voltage-dependency of the nicotine activated current was not modified by hirsutine. Effects of hirustine on other ion channels were tested to determire its selec tivity. Inward currents mediated through ATP-activated channels were scarcely affected by hirsutine (up to 100 1uM). However, hirustine (10,uM) inhibited Ba cur rents passing through Ca channels and K currents activated by depolarizing voltage steps. The results suggest that hirsutine potently blocks nicotinic receptor-channels, but hirsutine also inhibits voltage-gated Ca and K channels. Roles of the inhibition of these channels in the pharmacological effects of hirsutine were discussed. Hirsutine ( Fig. 1) is one of the indole alka loids isolated from Uncaria genus (1), and its ganglion blocker-like effects have been re ported. Hirsutine inhibited the preganglionic nerve-mediated contractions of guinea pig (2) and dog urinary bladder (3) without affecting the contractions induced by exogenous acetyl choline in situ. Action potentials of postgan glionic nerves in response to preganglionic nerve-stimulation were suppressed by hirsutine in rat superior cervical ganglion. As hirsutine was less potent in blocking neuromuscular transmission in rat limbs (4), hirsutine may affect responses mediated through ganglion type nicotinic receptors preferentially over those mediated through muscle-type nicotinic receptors as is the case for hexamethonium (C6) PC12 cells, a cell line derived from a rat pheochromocytoma (5), has retained the abil ity to release catecholamines in response to stimulations including exogenous nicotinic stimulation (e.g., 6, 7), so they are widely used in studies on neurosecretion. PC12 cells are known to possess ganglion-type nicotinic receptors (8) and are suitable for studying mechanisms underlying ganglion-blocking effects.
In the present study, we used PC12 cells to determine whether hirsutine inhibits nicotinic acetylcholine receptor-channels. The nicotinic receptor-channels are primarily responsible for neurotransmission in ganglions (9) and targets of C6 (10, 11) . We also tested the effects of hirsutine on other ion channels in these cells.
MATERIALS AND METHODS
Cell culture PC12 cells were prepared as previously de scribed by Inoue and Kenimer (7). In brief, PC12 cells were cultured in Dulbecco's Mod ified Eagle's Medium containing 7% fetal bovine serum, 7% heat-inactivated horse serum, 2 mM L-glutamine, and 50,u g/ml gen tamicin sulfate at 37°C in an atmosphere of 10% C02, and then plated onto collagen coated polystyrene dishes at 1 X 106 cells per dish. After an additional 2 to 3 day-culture, the cells were used for the experiments.
Dopamine-release
Release of dopamine from PC12 cells was measured by a modification of a previously re ported procedure (7). The dishes containing cultured PC12 cells were incubated with 1 ml of balanced salt solution (BS) containing: 150 mM NaCI, 5 mM KCI, 1.8 mM CaC12, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 10 mM glucose, 0.1 mM EDTA, and 2.5 mM HEPES (pH ad justed to 7.4 with NaOH) for 1 hr at room temperature. After washing once with BS (1 ml), the cells were treated with the desired concentration of hirsutine or C6 for 30 sec. The cells were then stimulated by ATP in the absence or presence of hirsutine or C6. The incubation solution was removed 1 min after the ATP-application and mixed with 0.25 ml of 1 N perchloric acid for measurement of the dopamine released into the solution. The cells remaining in the dishes were disrupted by sonication after adding 1 ml of 0.2 N perchlo ric acid. Both the incubation solution and the sonicated cellular solutions were centrifugated (at 5°C for 2 min, 1000 X g), and the super natants were collected for measurements of the dopamine content.
Dopamine content was determined with a high-pressure liquid chromatography-electro chemical detector (HPLC-ECD) system (Bioanalytical Systems). Ten microliters of the supernatants were applied to the HPLC sys tem which consisted of a reverse phase column (4.6 mm X 150 mm, ODS 3,um, Bioanalytical Systems) and an ECD with the electrode potential set at +0.7 V versus the Ag/AgCl reference electrode. The mobile phase con sisted of a mono chloroacetate buffer (140 mM, pH 3.05) containing 10% methanol, 30 mg/l sodium 1-octanesulfonate and 1.8 mM EDTA (flow rate, 0.9 ml/min). The data was analyz ed with a chromatographic data processor (Shimadzu C-R4A).
Percent secretion was calculated using the values obtained for dopamine content in the incubation solution (A) and dopamine content remaining in the cells (B) by the following equation: % of total dopamine/min = 100 X A/(A + B).
Electrophysiological study
Membrane potentials and currents were measured using whole-cell recordings of im proved patch-clamp techniques (12) . The cells were continuously superfused with an ex tracellular solution containing 140 mM NaCI, 5.4 mM KCI, 1.8 mM CaC12, LO MM MgC12, 11.1 mM glucose and 10.0 mM N-2-hydro xyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (adjusted with NaOH to pH 7.4). The heat-polished patch pipettes had tip resist ances of about 5 MQ when filled with an in tracellular solution containing 150 mM CsCI, 10.0 mM HEPES and 5.0 mM glycolether diamine-N,N,N',N'-tetraacetic acid (EGTA) (pH was adjusted to 7.3 with CsOH). In the measurements of K currents, CsCI in the in tracellular solution was replaced with KCI, and the pH was adjusted with KOH. For the measurements of Ba currents permeating through voltage-gated Ca channels, extracellu lar CaClz was replaced with BaCl2 (10.8 mM). Cd (300 ,u M) was applied at the end of each experiment to block the Ca channels com pletely (13) . The amplitude of the Ba current was determined by subtracting the current traces obtained with 300,uM Cd. Membrane currents were monitored on a storage oscillo scope (Nihon Kohden VC-11) via a patch clamp amplifier (Nihon Kohden CEZ-2200). Electrical signals were filtered at 1 kHz and stored on magnetic tape for later analysis. The experiments were performed at room tempera ture (about 25°C).
Hirsutine was a gift from Prof. Shinichiro Sakai of Chiba University. (-)-Nicotine hy drogen tartrate salt and adenosine 5'-triphos phate disodium salt were purchased from Sig ma (St. Louis, MO, U.S.A.). Hexamethonium bromide was obtained from Wako Pure Chem icals (Osaka, Japan). All drugs were applied to cells by superfusion. In estimating the effects of hirustine, the cells were only ex posed to nicotine or ATP for a brief period (about 7 sec) to avoid desensitization of nicotinic-receptor channels (14, 15) or ATP activated channels (16, 17) . 
RESULTS

Effects of hirsutine on nicotine-evoked dopamine-release
We first tested whether hirsutine blocks nicotine-evoked dopamine-release from PC12 cells. Both hirsutine (1 to 10 ,u M) and C6 (10 ,u M) inhibited dopamine-release evoked by 100,uM nicotine (Fig. 2) . The inhibition in duced by 10 ,u M hirsutine was larger than that induced by 10 ,u M C6. We regarded these cells as a model for postganglionic cells in nicotinic neurotransmission and used them to clarify the mechanisms uderlying the ganglionic blocking actions of hirsutine described in the following sections.
Effects of hirsutine on nicotine-activated chan nels Figure 3A shows the inhibitory action of hirsutine (1 uM) on the inward current acti vated by 100,uM nicotine. Hirsutine was pres ent 10 sec before and during the application of nicotine in this case. The inhibition was not augmented with a longer (1 min) pretreatment with hirsutine (not shown). A full recovery was observed about 2 min after the rinse with a drug-free solution (Fig. 3A) . Hirustine in hibited the nicotine-activated current in a con centration-dependent manner (Fig. 3B) . The inhibition induced by 1 u M hirsutine was com parable to that induced by IPM C6 (Fig. 3B) . The inhibition induced by hirsutine was slight ly overcome by an increase of nicotine; the in ward current remaining after inhibition by 1 M M hirsutine was 57.3 ± 2.7% of the control (mean ± S.E.M., n = 7) for a higher concen tration (1 mM) of nicotine, which was larger than the value (40.2 ± 2.9% of control, n = 7) for 100 ,uM nicotine.
We tested whether hirsutine affects these channels in a voltage-dependent manner. First, we applied to the cells hyperpolarizing test pulses from -30 mV to -100 mV periodically (not shown). The rate of reduc tion by 1 ,uM hirustine of the nicotine (100 ,u M)-activated inward current was not differ ent between -30 and -100 mV: the current was reduced to 43.6 ± 7.8% of the control at -30 mV and 38 .5 ± 8.2% of the control at -100 mV (mean ± S .E.M., n = 4). Next we applied a ramp pulse to the cells to determine the reversal potential of the nicotine-activated current (Fig. 4) . The nicotine-activated current under the control condition was reversed around 0 mV, which might reflect a poor ion selectivity of nicotinic receptor channels (9) . The reversal potential was not affected by hir sutine (1 ,uM). These results suggest that hir sutine does not affect the nicotine-activated current in a voltage-dependent manner. 
Effects of hirsutine on other channels
We tested the selectivity of the effects of hirsutine among various types of ion channels. First, we examined its effect on ATP-activated channels which we previously found and char acterized in PC12 cells (16) (17) (18) . Figure 5 shows the inward current activated by 100,uM ATP. The ATP-activated current in the pres ence of 10 ,u M hirsutine was 103.8 ± 5.0% of the control (mean ± S.E.M., n = 7) and that in the presence of 100 ,u M hirsutine was 84.3 ± 7.1% of the control (n = 3). This result suggests that hirsutine can discriminate be tween these ligand-gated channels and nicotin ic receptor-channels.
We then examined the effects of hirsutine on voltage-gated channels. Figure 6 shows the effects of hirsutine on Ca channels. Ba (10.8 mM) was used as a charge-carrier to obtain a large inward current (13) . Hirsutine (1 to 100 ,uM) inhibited the Ba current. The inhibition was rapid in onset (Fig. 6B) . The concentra tion-dependency of the inhibition of the Ba current (Fig. 6C) was not much different from that of the inhibition of the nicotinic receptor channels:
for example, re duced the Ba current to 68.3% of the control (Fig. 6Q , whereas the drug reduced the nicotine-activated current to 40.2% of the con trol (Fig. 3C) . Hirsutine did not significantly affect the voltage-dependency of the Ba cur rent (Fig. 6D) . Figure 7A shows an outward current acti vated by a depolarizing pulse to + 10 mV obtained from a K-loaded cell. The outward current is mediated through K channels (14, 19) . Ca channels were not blocked because the amplitude of the Ca current with 1.8 mM Ca in these cells (ca. 20 pA, ref. 14) was neg ligible as compared with the apparent outward current (more than 500 pA, Fig. 7) . Hirsutine also inhibited the K current (Fig. 7A) . Hirsu tine (10,uM) inhibited the K current to the same extent as the nicotine activated current (Fig. 3C ) or the Ba current (Fig. 6C ) (52.1 ± 2.9% of the control, mean ± S.E.M., n = 6). The inhibition of the K current was rapid in onset (Fig. 7B) as was the case for that of the Ba current (Fig. 6) . Fig. 4 . Voltage-dependency of the nicotine (100 ,uM)-activated current in the absence (A) or the presence (B) of hirsutine (1 uM) obtained from a PC12 cell. The cell was held at a -70 mV, and a ramp pulse to + 30 mV (+ 100 mV/sec) was applied every 2 sec. The current trace during the ramp pulse near the peak nicotine-activated current was superimposed on the trace just before the nicotine-application in each panel. Each application of nicotine was separated by 1 min. Hirsutine was present 10 sec before and throughout the nicotine-application (B). 6 . Effects of hirsutine on Ba current permeating through voltage-gated Ca channels. A. The Ba cur rent recorded from a PC12 cell. The current was activated by a 400 msec test pulse to +10 mV every 5 sec from a holding potential of -60 mV. The current traces just before (control) and 1 min after application of 1,uM hirsutine (hirsutine) were superimposed. B. Time course of inhibition by hirsutine (10,uM) of the Ba current obtained from another cell. The Ba current was activated by a test pulse from -60 mV to +10 mV. Hirsutine was applied at time indicated with an arrow and continuously present afterwards. C. Concentratin-dependency. Cells were held at -60 mV, and Ba currents were elicited by a test potential to + 10 mV every 5 sec. Peak Ba current 1 min after application of each concentration of hirsutine was normal ized to that just before the hirsutine application. Each column represents the mean of 5 (1 'UM), 4 (10 PM) or 2 (100,uM) cells tested. Vertical bars show the S.E.M. D. Current-voltage relationship for Ba currents obtained from a cell. The cell was held at -60 mV, and 200 msec test pulses to various potentials were applied every 5 sec. During repetitive application of these test pulses, the cell was exposed to hirsutine (1 ,uM). Each symbol represents the peak Ba-current just before (control: open circles) and that 1 to 2 min after the exposure to hirsutine (hirsutine: filled circles).
DISCUSSION
We have characterized the effects of hirsu tine, an alkaloid which exerts ganglion blocking-like action (2, 3, 20), on ion channels using pheochromocytoma PC12 cells. Hirsu tine inhibited nicotinic receptor channels at concentrations of u M order, which is compa rable to the inhibition induced by C6. The re sults suggest that components of herbal drugs like hirsutine can also block neuronal nicotinic receptor-channels as well as synthetic positive ly charged molecules such as C6 or toxins such as d-tubocurarine (21) . Hirsutine also blocked voltage-gated Ca and K channels, suggesting that hirsutine inhibits non-selectively a variety of ion channels.
Hirsutine inhibited nicotine-evoked dop amine-release from PC12 cells more potently than C6 (Fig. 2) in spite of the fact that these antagonists were equipotent in blocking the nicotine-activated current (Fig. 3) . A consider able part of nicotine-evoked catecholamine-re lease depends on Ca-influx mediated through Ca channels secondly activated by depolariza tion in PC12 cells (22, 23) . Thus, the potent inhibition by hirsutine of the dopamine-release may be due to blockade by hirsutine of Ca channels (Fig. 6 ) in addition to nicotinic receptor-channels (Fig. 3) . In smooth muscle tissues, nerve-mediated contraction of guinea pig (2) and dog urinary bladder (3) was inhib ited equally by hirsutine and C6. The blockade of Ca channels by hirsutine may not play a role in the ganglionic blocking actions in these smooth muscle tissues.
Ascher et al. (10) compared blocking prop erties of various nicotinic antagonists in rat parasympathetic ganglion cells. They showed that some nicotinic antagonists including C6 preferentially inhibit the inward current medi ated through nicotinic receptor-channels at negative potentials, and they concluded that this phenomenon is due to blockade of ion permeation through the open-state of the channels. In the present study, we did not find such voltage-dependent inhibition by hirsutine of the nicotine-activated current (Fig. 4) . Our results may indicate that hirsutine is not such an "open-channel blocker". The attenuation of hirustine-induced inhibition by an increment of nicotine concentration suggests that hirsu tine affects agonist-binding to nicotinic recep tors.
We have shown that hirsutine, an alkaloid isolated from Uncaria genus, affects nicotinic acetylcholine channels as well as voltage-gated Ca and K channels. Hirsutine may not be usu able as a pharmacological tool because of its non-selective nature of ion channel inhibition. However, combined inhibition of nicotinic receptor-channels and Ca channels may work cooperatively in some cases, which may be re levant to the pharmacological effects of hirsu tine. For example, hirsutine exerts anti hypertensive effects, which is one of the major purposes of clinical application of Uncaria genus (24) . These antihypertensive effects may be due to such a cooperative inhibition by hir sutine of nicotinic receptor-channels and Ca channels: the nicotinic receptor-channel inhibi tion may result in a decrease in catechol amine-release from the adrenal medulla, and the Ca channel inhibition may result in attenu ation of vascular smooth muscle tone. Con tribution of Ca channel inhibition by other in dole alkaloids extracted from Uncaria genus, which have similar structures to hirsutine, to the antihypertensive effects was also suggested from measurements of mechanical responses of isolated blood vessels (25) . Channel inhibi tion may also be related to other pharmaco logical actions of hirsutine or Uncaria genus including those on central nervous systems (26) . Fig. 7 . Effects of hirsutine on K current. A. K cur rent recorded from a PC12 cell. The K current was activated by a test pulse from -60 mV to + 10 mV ev ery 5 sec. The K currents just before (control) and 1 min after application of 10 ,u M hirsutine (+ hirsutine) were superimposed. B. Time course of inhibition by hirsutine of the K current obtained from another cell. Hirsutine (10,uM) was applied at time indicated with an arrow and was continuously present afterwards.
